Volume 24, Number 2—February 2018
Research
Trends in Infectious Disease Mortality, South Korea, 1983–2015
Table 4
Disease | Mortality rate |
AAPC, 1983–2015 | Trend 1 |
Trend 2 |
Trend 3 |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1983 | 2015 | Period | APC | Period | APC | Period | APC | ||||
All infectious disease |
43.5 |
44.6 |
0.44 |
1983–1991 |
−9.73 |
1991–2006 |
0.67 |
2006–2015 |
8.97 |
||
Respiratory tract infections | 15.1 | 19.5 | 1.06 | 1983–1992 | −8.89 | 1992–2007 | 1.83 | 2007–2015 | 11.47 | ||
Sepsis | 0.8 | 4.0 | 3.80 | 1983–2000 | 8.62 | 2000–2003 | −20.38 | 2003–2015 | 6.99 | ||
Tuberculosis | 23.7 | 3.0 | −5.97 | 1983–1989 | −9.12 | 1989–2015 | −5.55 | ||||
Intestinal infections | 4.3 | 0.9 | −2.62 | 1983–1988 | −14.30 | 1988–2004 | −4.50 | 2004–2015 | 5.48 | ||
Vaccine-preventable diseases | 1.1 | 0.0 | −1.71 | 1983–1987 | −10.97 | 1987–1996 | −3.00 | 1996–2015 | −0.33 | ||
CNS infections | 3.1 | 0.3 | −2.71 | 1983–1986 | −13.94 | 1986–1992 | −5.50 | 1992–2015 | −1.62 | ||
Viral hepatitis | 0.0 | 1.0 | 3.24 | 1983–1998 | 2.75 | 1998–2007 | 7.92 | 2007–2015 | −4.99 | ||
HIV diseases | 0.0 | 0.2 | 0.70 | 1983–1998 | −0.01 | 1998–2001 | 2.85 | 2001–2015 | 0.77 | ||
Rheumatic heart diseases | 0.5 | 0.2 | −0.35 | 1983–1999 | −1.40 | 1999–2002 | 9.31 | 2002–2015 | −2.24 |
*AAPC, average annual percentage change; APC, annual percentage change in age-standardized mortality rate; CNS, central nervous system. Mortality rates expressed as deaths/100,000 population. Values in bold indicate where AAPC or APC differed significantly (p<0.05) from zero (by a 2-sided test for which the true AAPC was zero, calculated based on a t distribution; https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/average-annual-percent-change-aapc).
Page created: January 17, 2018
Page updated: January 17, 2018
Page reviewed: January 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.